Search

Your search keyword '"von Elm Erik B"' showing total 2 results
Start Over Author "von Elm Erik B" Language english
2 results on '"von Elm Erik B"'

1. Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study)

Author

Kasenda Benjamin, von Elm Erik B, You John, Blümle Anette, Tomonaga Yuki, Saccilotto Ramon, Amstutz Alain, Bengough Theresa, Meerpohl Jörg, Stegert Mihaela, Tikkinen Kari A O, Neumann Ignacio, Carrasco-Labra Alonso, Faulhaber Markus, Mulla Sohail, Mertz Dominik, Akl Elie A, Bassler Dirk, Busse Jason W, Ferreira-González Ignacio, Lamontagne Francois, Nordmann Alain, Rosenthal Rachel, Schandelmaier Stefan, Sun Xin, Vandvik Per O, Johnston Bradley C, Walter Martin A, Burnand Bernard, Schwenkglenks Matthias, Bucher Heiner C, Guyatt Gordon H, and Briel Matthias

Subjects
Randomized controlled trial, Trial discontinuation, Slow recruitment, Ethics committees, Trial protocols, Medicine (General), R5-920
Abstract

Abstract Background Randomized controlled trials (RCTs) may be discontinued because of apparent harm, benefit, or futility. Other RCTs are discontinued early because of insufficient recruitment. Trial discontinuation has ethical implications, because participants consent on the premise of contributing to new medical knowledge, Research Ethics Committees (RECs) spend considerable effort reviewing study protocols, and limited resources for conducting research are wasted. Currently, little is known regarding the frequency and characteristics of discontinued RCTs. Methods/Design Our aims are, first, to determine the prevalence of RCT discontinuation for specific reasons; second, to determine whether the risk of RCT discontinuation for specific reasons differs between investigator- and industry-initiated RCTs; third, to identify risk factors for RCT discontinuation due to insufficient recruitment; fourth, to determine at what stage RCTs are discontinued; and fifth, to examine the publication history of discontinued RCTs. We are currently assembling a multicenter cohort of RCTs based on protocols approved between 2000 and 2002/3 by 6 RECs in Switzerland, Germany, and Canada. We are extracting data on RCT characteristics and planned recruitment for all included protocols. Completion and publication status is determined using information from correspondence between investigators and RECs, publications identified through literature searches, or by contacting the investigators. We will use multivariable regression models to identify risk factors for trial discontinuation due to insufficient recruitment. We aim to include over 1000 RCTs of which an anticipated 150 will have been discontinued due to insufficient recruitment. Discussion Our study will provide insights into the prevalence and characteristics of RCTs that were discontinued. Effective recruitment strategies and the anticipation of problems are key issues in the planning and evaluation of trials by investigators, Clinical Trial Units, RECs and funding agencies. Identification and modification of barriers to successful study completion at an early stage could help to reduce the risk of trial discontinuation, save limited resources, and enable RCTs to better meet their ethical requirements.

Published
2012
Full Text
View/download PDF

2. Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study)

Author

Kasenda, Benjamin, Von Elm, Erik B, You, John, Blümle, Anette, Tomonaga, Yuki, Saccilotto, Ramon, Amstutz, Alain, Bengough, Theresa, Meerpohl, Jörg, Stegert, Mihaela, Tikkinen, Kari A O, Neumann, Ignacio, Carrasco-Labra, Alonso, Faulhaber, Markus, Mulla, Sohail, Mertz, Dominik, Akl, Elie A, Bassler, Dirk, Busse, Jason W, Ferreira-González, Ignacio, Lamontagne, Francois, Nordmann, Alain, Rosenthal, Rachel, Schandelmaier, Stefan, Sun, Xin, Vandvik, Per O, Johnston, Bradley C, Walter, Martin A, Burnand, Bernard, Schwenkglenks, Matthias, Bucher, Heiner C, Guyatt, Gordon H, and Briel, Matthias

Subjects
3. Good health
Abstract

Background Randomized controlled trials (RCTs) may be discontinued because of apparent harm, benefit, or futility. Other RCTs are discontinued early because of insufficient recruitment. Trial discontinuation has ethical implications, because participants consent on the premise of contributing to new medical knowledge, Research Ethics Committees (RECs) spend considerable effort reviewing study protocols, and limited resources for conducting research are wasted. Currently, little is known regarding the frequency and characteristics of discontinued RCTs. Methods/Design Our aims are, first, to determine the prevalence of RCT discontinuation for specific reasons; second, to determine whether the risk of RCT discontinuation for specific reasons differs between investigator- and industry-initiated RCTs; third, to identify risk factors for RCT discontinuation due to insufficient recruitment; fourth, to determine at what stage RCTs are discontinued; and fifth, to examine the publication history of discontinued RCTs. We are currently assembling a multicenter cohort of RCTs based on protocols approved between 2000 and 2002/3 by 6 RECs in Switzerland, Germany, and Canada. We are extracting data on RCT characteristics and planned recruitment for all included protocols. Completion and publication status is determined using information from correspondence between investigators and RECs, publications identified through literature searches, or by contacting the investigators. We will use multivariable regression models to identify risk factors for trial discontinuation due to insufficient recruitment. We aim to include over 1000 RCTs of which an anticipated 150 will have been discontinued due to insufficient recruitment. Discussion Our study will provide insights into the prevalence and characteristics of RCTs that were discontinued. Effective recruitment strategies and the anticipation of problems are key issues in the planning and evaluation of trials by investigators, Clinical Trial Units, RECs and funding agencies. Identification and modification of barriers to successful study completion at an early stage could help to reduce the risk of trial discontinuation, save limited resources, and enable RCTs to better meet their ethical requirements.

Catalog

Books, media, physical & digital resources
See catalog results